For women aged 30 to 39 years, either ultrasound or diagnostic mammography may be used for initial evaluation. \{MRI\} is rarely indicated to evaluate a clinically detected finding. Biopsy is indicated for masses with suspicious features. Short-term follow-up is a reasonable alternative to ...
p Newport Diagnostic Center,Newport Beach,California.q University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School,New Brunswick,New Jersey. Corresponding author and reprints:Martha B.Mainiero,MD,American College of Radiology,1891Preston White Drive,Reston,VA20191; e-mail:m...
Risks of Mammography Screening The primary, quanti?able risks of screening mammography are recall for additional imaging and, after diagnostic eval- uation, recommendation for biopsy that yields benign results. Recall occurs when an abnormality identi?ed at screening requires further evaluation; if the...
Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy Br J Radiol, 85 (2012), pp. e1074-e1082 CrossrefView in ScopusGoogle Scholar 27 Y. Takamoto, H. Tsunoda, M. Kikuchi, et al. Role of breast tomosynthesis in diagnosis of breast cancer for Japanese women Asian...
For women aged 30 to 39 years, either ultrasound or diagnostic mammography may be used for initial evaluation. \\{MRI\\} is rarely indicated to evaluate a clinically detected finding. Biopsy is indicated for masses with suspicious features. Short-term follow-up is a reasonable alternative to ...
Screening for breast cancer with mammography has been shown to decrease mortality from breast cancer, and mammography is the mainstay of screening for clin... Stephens,W T. - 《Yearbook of Diagnostic Radiology》 被引量: 0发表: 2011年 The Effect of the Controversial US Preventive Services Task...
For women aged 30 to 39 years, either ultrasound or diagnostic mammography may be used for initial evaluation. MRI is rarely indicated to evaluate a clinically detected finding. Biopsy is indicated for masses with suspicious features. Short-term follow-up is a reasonable alternative to biopsy for...
First: modifier N (non-diagnostic) Second: modifier S (stent) Third: modifier G (graft) Fourth: modifier V (vulnerability) ∗ CAD-RADS 1—This category should also include the presence of plaque with positive remodeling and no evidence of stenosis. † CAD-RADS 2—Modifier 2/V can be ...
However, as discussed above, many factors can influence the technical diagnostic performance of AI tools in clinical practice. While it has been suggested that the combination of human reader and AI tool could help increase overall diagnostic accuracy by either the human detecting an error made by...
Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions 2017, Diagnostic and Interventional Imaging Implications of Direct Patient Online Access to Radiology Reports Through Patient Web Portals ...